Organon (OGN) Stock Highlights

14.58 | +0.97%

2024-12-21 02:30:37

Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within womens health, biosimilars, and established brands. Geographically, it derives a majority of revenue from Europe and Canada.

Statistics

Range Today

14.41 14.91

Volume Today 31.56M

Range 1 Year

13.14 23.1

Volume 1 Year 594.56M

Range 3 Year

10.84 39.47

Volume 3 Year 1.8B

Range 10 Year

10.84 39.47

Volume 10 Year 2.22B

Highlights

Market Capitalization 4.13B (mid)

Floating Shares 256.71M

Current Price 14.58

Price To Earnings 3.21

Price To Revenue 1.89

Price To Book 8.38

Earnings Per Share 5.05

Dividend Yield 6.95%

Dividend Per Share 1.12

Payout Ratio 22.18%

Performance

Latest +0.97%

1 Month -0.07%

3 Months -27.43%

6 Months -27.89%

1 Year +8.24%

3 Years -51.4%

5 Years -52.97%

10 Years -52.97%

Benchmarks

Market Capitalization

12 / 14

Gross Profits

12 / 14

Total Revenue

12 / 14

Total Rank

9 / 14

Free Cashflow

11 / 14

Performance 5 years

12 / 14

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.